These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10741262)

  • 1. [Therapy of primary open-angle glaucoma by oftan-dipivefrin].
    Egorov EA; Alekseev VN; Erichev VP; Usachev VV; Simonova SV; Iakubova LV
    Vestn Oftalmol; 2000; 116(1):32-3. PubMed ID: 10741262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Guanethidine/dipivefrin and pilocarpine in the treatment of increased intraocular pressure].
    Ober M; Scharrer A; Dausch D
    Klin Monbl Augenheilkd; 1987 Feb; 190(2):103-4. PubMed ID: 3573660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Remote results of proxopheline therapy of patients with primary open-angle glaucoma].
    Ermakova VN; Malinina SL; Abdulkadyrova MZh
    Vestn Oftalmol; 2000; 116(5):27-9. PubMed ID: 11221374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasolacrimal occlusion improves the therapeutic index of antiglaucoma medications.
    Sharir M; Zimmerman TJ
    J Assoc Acad Minor Phys; 1994; 5(2):62-7. PubMed ID: 8032178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The additive effect of dipivefrin in patients with wide angle glaucoma treated with long-term beta-blocker therapy in comparison with clonidine].
    Alimgil ML; Erda S; Benian O
    Klin Monbl Augenheilkd; 1994 Aug; 205(2):114-6. PubMed ID: 7967405
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of diclofenac ophthalmic solution on the intraocular pressure-lowering effect of topical 0.5% timolol and 0.005% latanoprost in primary open-angle glaucoma patients.
    Costagliola C; Parmeggiani F; Antinozzi PP; Caccavale A; Cotticelli L; Sebastiani A
    Exp Eye Res; 2005 Nov; 81(5):610-5. PubMed ID: 15949795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open-angle glaucoma: a randomized, controlled, investigator-blinded study.
    Reis R; dos Santos LC; Vila MP; Magacho L
    Clin Ther; 2004 Dec; 26(12):2121-7. PubMed ID: 15823775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The pressure reducing effects of pilocarpin in combination with Dipivalyl-epinephrine in glaucoma simplex (author's transl)].
    Krieglstein GK; Leydhecker W
    Klin Monbl Augenheilkd; 1979 Jul; 175(1):86-90. PubMed ID: 491472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension.
    Schuman JS; Katz GJ; Lewis RA; Henry JC; Mallick S; Wells DT; Sullivan EK; Landry TA; Bergamini MV; Robertson SM
    Am J Ophthalmol; 2005 Aug; 140(2):242-50. PubMed ID: 16086946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pilaren in the therapy of open-angle glaucoma].
    Erichev VP; Maĭchuk IuF
    Vestn Oftalmol; 1988; 104(5):16-9. PubMed ID: 3222825
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of glaucoma with a pilocarpine-dipivefrin combination (author's transl)].
    Niedermeier S
    Klin Monbl Augenheilkd; 1981 Mar; 178(3):210-1. PubMed ID: 7230718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of combined conservative treatment of patients with initial open-angle glaucoma].
    Luchik VI
    Oftalmol Zh; 1989; (2):75-7. PubMed ID: 2755664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative analysis of life quality in patients receiving beta-blockers and xalathane (latanoprost)].
    Tugushi OA; Shliapuzhnikova AV; Listopadova NA
    Vestn Oftalmol; 2005; 121(4):41-3. PubMed ID: 16223045
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of 0.1% dipivefrine chloride for treatment of patients with open angle glaucoma].
    Czechowicz-Janicka K; Kamińska E; Staszkiewicz J
    Klin Oczna; 1995; 97(7-8):248-51. PubMed ID: 8531459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The safety and efficacy of travoprost 0.004%/timolol 0.5% fixed combination ophthalmic solution.
    Barnebey HS; Orengo-Nania S; Flowers BE; Samples J; Mallick S; Landry TA; Bergamini MV
    Am J Ophthalmol; 2005 Jul; 140(1):1-7. PubMed ID: 15990081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.